1. Harrison, C.J. The management of patients with leukaemia: The role of cytogenetics in this molecular era. Br. J. Haematol. 2000, 108, 19 - 30.

2. Grimwade, D.; Walker, H.; Oliver, F.; Wheatley, K.; Harrison, C.; Harrison, G.; Rees, J.; Hann, I.; Stevens, R.; Burnett, A.; Goldstone, A. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998, 92, 2322-2333.

3. Le Beau, M.M. Detecting genetic changes in human tumor cells: Have scientists ''gone fishing?''. Blood 1993, 81, 1979-1983.

4. Dohner, H.; Stilgenbauer, S.; Benner, A.; Leupolt, E.; Krober, A.; Bullinger, L.; Dohner, K.; Bentz, M.; Lichter, P. Genomic aberrations and survival in chronic lympho-cytic leukemia. N. Engl. J. Med. 2000, 343, 1910-1916.

5. Martin-Subero, J.I.; Gesk, S.; Harder, L.; Grote, W.; Siebert, R. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res. 2003, 23, 1139-1148.

6. Gozzetti, A.; Le Beau, M.M. Fluorescence in situ hybridization: Uses and limitations. Semin. Hematol. 2000, 37, 320-333.

7. Romana, S.P.; Poirel, H.; Leconiat, M.; Flexor, M.A.; Mauchauffe, M.; Jonveaux, P.; Macintyre, E.A.; Berger, R.; Bernard, O.A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995, 86, 4263 -4269.

8. Fassas, A.B.; Spencer, T.; Sawyer, J.; Zangari, M.; Lee, C.K.; Anaissie, E.; Muwalla, F.; Morris, C.; Barlogie, B.; Tricot, G. Both hypodiploidy and deletion of chromosome

13 independently confer poor prognosis in multiple myeloma. Br. J. Haematol. 2002, 118, 1041-1047.

9. Lai, F.; Godley, L.A.; Joslin, J.; Fernald, A.A.; Liu, J.; Espinosa, R., III; Zhao, N.; Pamintuan, L.; Till, B.G.; Larson, R.A.; Qian, Z.; Le Beau, M.M. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q). Genomics 2001, 71, 235-245.

10. Bumm, T.; Muller, C.; Al-Ali, H.K.; Krohn, K.; Shepherd, P.; Schmidt, E.; Leiblein, S.; Franke, C.; Hennig, E.; Friedrich, T.; Krahl, R.; Niederwieser, D.; Deininger, M.W. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood 2003, 101, 1941-1949.

11. Kallioniemi, A.; Kallioniemi, O.P.; Sudar, D.; Rutovitz, D.; Gray, J.W.; Waldman, F.; Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258, 818-821.

12. Nederlof, P.M.; van der Flier, S.; Wiegant, J.; Raap, A.K.; Tanke, H.J.; Ploem, J.S.; van der Ploeg, M. Multiple fluorescence in situ hybridization. Cytometry 1990, 11, 126-131.

13. Speicher, M.R.; Gwyn Ballard, S.; Ward, D.C. Karyotyp-ing human chromosomes by combinatorial multi-fluor FISH. Nat. Genet. 1996, 12, 368-375.

14. Veldman, T.; Vignon, C.; Schrock, E.; Rowley, J.D.; Ried, T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat. Genet. 1997, 15, 406-410.

15. Le Beau, M.M. One FISH, two FISH, red FISH, blue FISH. Nat. Genet. 1996, 12, 341-344.

16. Odero, M.D.; Carlson, K.M.; Calasanz, M.J.; Rowley, J.D. Further characterization of complex chromosomal rearrangements in myeloid malignancies: Spectral karyotyping adds precision in defining abnormalities associated with poor prognosis. Leukemia 2001, 15, 1133-1136.

17. Martin-Subero, J.I.; Chudoba, I.; Harder, L.; Gesk, S.; Grote, W.; Novo, F.J.; Calasanz, M.J.; Siebert, R. Multicolor-FICTION: Expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am. J. Pathol. 2002, 161, 413-420.

18. Odero, M.D.; Carlson, K.; Calasanz, M.J.; Lahortiga, I.; Chinwalla, V.; Rowley, J.D. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 2001, 31, 134-142.

19. Odero, M.D.; Vizmanos, J.L.; Roman, J.P.; Lahortiga, I.; Panizo, C.; Calasanz, M.J.; Zeleznik-Le, N.J.; Rowley, J.D.; Novo, F.J. A novel gene, MDS2, is fused to ETV6/ TEL in a t(1;12)(p36.1;p13) in a patient with myelodys-plastic syndrome. Genes Chromosomes Cancer 2002, 35, 11-19.

FISH—Centromere-Specific Multicolor FISH

Thomas Liehr

Institut für Humangenetik und Anthropologie der FSU Jena, Jena, Germany

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment